In both crude and adjusted hepatic lipid contents, IGFBPs were predictor of NAFLD stage as follows: IGFBP-1 for bNASH and IGFBP-2 for every NAFLD stages (SS, bNASH, and NASH) (Table 1). Here, IGFBP1 is linked to metabolic dysfunction-associated steatotic liver disease.